Keywords: shantha, plans, mill, nasdaq, listing, india, hyderabad-based
Shantha plans $100 mill Nasdaq listing
Article | 18 September 2000
India's Hyderabad-based Shantha Biotechnics, which was the first companyin the country to develop a recombinant hepatitis B virus vaccine, will ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
